[Clinical evaluation of the therapeutic effects of Debridat in carcinology].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002082:Butylamines / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000188:drug therapy*; D003967:Diarrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008298:Maleates / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care; D010276:Parasympatholytics / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy*
D000700:Analgesics; D001565:Benzoates; D002082:Butylamines; D008298:Maleates; D010276:Parasympatholytics
Appréciation clinique des effets thérapeutiques du Debridat en carcinologie.